Influenza-Associated Pediatric Deaths Case Report Form

Similar documents
Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No

Human Infection with Novel Influenza A Virus Case Report Form

Pediatric influenza-associated deaths in Arizona,

Microbiology Laboratory Directors, Infection Preventionists, Primary Care Providers, Emergency Department Directors, Infectious Disease Physicians

Influenza A (H1N1)pdm09 in Minnesota Epidemiology

Epidemiology of Infectious Complications of H1N1 Influenza Virus Infection

Influenza in the pediatric population

Invasive Bacterial Disease

Chickenpox Death. West Virginia Electronic Disease Surveillance System

Community Acquired Pneumonia

Tuberculosis in Chicago 2007

Pertussis. West Virginia Electronic Disease Surveillance System

Invasive Bacterial Disease

Utah Influenza Report This report contains data through the week ending 12/15/2012 (MMWR week 50).

PEDIATRIC INFLUENZA CLINICAL PRACTICE GUIDELINES

2009 Pandemic Influenza A (H1N1) Deaths among Children United States,

Haemophilus influenzae Surveillance Report 2012 Oregon Active Bacterial Core Surveillance (ABCs) Center for Public Health Practice Updated: July 2014

Of 142 cases where sex was known, 56 percent were male; of 127cases where race was known, 90 percent were white, 4 percent were

THIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE

Seasonal Influenza. Provider Information Sheet. Infectious Disease Epidemiology Program

ESCMID Online Lecture Library. by author

Supplementary Appendix

Novel H1N1 Influenza A Update. William Muth MD 2 Oct 2009

Diphtheria. West Virginia Electronic Disease Surveillance System

The pages that follow contain information critical to protecting the health of your patients and the citizens of Colorado.

Incidence per 100,

COUNTY OF MORRIS DEPARTMENT OF LAW & PUBLIC SAFETY OFFICE OF HEALTH MANAGEMENT

Diagnosis of Seasonal and Pandemic Influenza. Objectives. Influenza Infections 11/7/2014

Rationale for recommendations

Source: Portland State University Population Research Center (

16 November 2017 National Immunisation Advisory Committee Recommendations for the 2017/2018 Influenza Vaccination Campaign

Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance

Tamiflu. Tamiflu (oseltamivir) Description

Seasonal Influenza Report

Respiratory Pathogen Panel TEM-PCR Test Code:

Clinical Guidance for 2009 H1N1 Influenza and Seasonal Influenza. Barbara Wallace, MD New York State Department of Health (Updated 10/8/09)

Seasonal Influenza Report

ACIP Recommendations

Methicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods

Seasonal Influenza Report

Protecting Infants and Children from Pertussis and Influenza

Swine Influenza Update #3. Triage, Assessment, and Care of Patients Presenting with Respiratory Symptoms

Immunization with Influenza Vaccine (Inf)

Released February Health Status of New Mexico 2018

Demographics and Health Data

Influenza. Tim Uyeki MD, MPH, MPP, FAAP

Proposed Data Collection Submitted for Public Comment and. AGENCY: Centers for Disease Control and Prevention (CDC),

Demographics and Health Data

Hepatitis Case Investigation

Supplementary Appendix

Pneumococcal Vaccine in Children: current situation

MCH-Immunization Conference. September 2012

Washoe County Health District Influenza Surveillance Program Final Hospitalization & Death Data

Supplementary Online Content

Incidence per 100,000

Streptococcus Pneumoniae

SEASONAL INFLUENZA VACCINE INFORMATION FOR IMMUNIZATION PROVIDERS

Federation of State Boards of Physical Therapy Minimum Data Set Questionnaire

Influenza Clinical Bulletin # 3: October 8, 2009 Vaccination Guidelines for Patients for Influenza

Self-study course. Pneumonia

Salt Lake County Annual Influenza Report Season Bureau of Epidemiology

Chapter 16 Pneumococcal Infection. Pneumococcal Infection. August 2015

Health Status of New Mexico 2015

Trends in Pneumonia and Influenza Morbidity and Mortality

H1N1 Global Pandemic Kevin Sherin, MD, MPH, FACPM, FAAFP Director Orange County Health Department

INFLUENZA (Outbreaks; hospitalized or fatal pediatric cases)

2007 ACIP Recommendations for Influenza Vaccine. Anthony Fiore, MD, MPH Influenza Division, NCIRD, CDC

TRENDS IN PNEUMONIA AND INFLUENZA MORBIDITY AND MORTALITY

A Just in Time Primer on H1N1 Influenza A and Pandemic Influenza developed by the National Association of State EMS Officials and Revised by the

EAST MULTICENTER STUDY DATA COLLECTION TOOL

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP

HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY

Update of the CDC/HICPAC Guideline: Infection Prevention in Healthcare Personnel

Flu & Pneumonia Provider Toolkit

IMPACT #: Local Inventory #: form 04. Age at admission: d. mo yr. Postal code:

WELCOME TO OUR OFFICE

Fever Without a Source Age: 0-28 Day Pathway - Emergency Department Evidence Based Outcome Center

Flu Vaccination. John Hann, MD UC Irvine Health

PBL RESPIRATORY SYSTEM DR. NATHEER OBAIDAT

High Risk Conditions and Vaccination Gaps in Invasive Pneumococcal Disease Cases in Tennessee,

Clinical and Molecular Characteristics of Community- Acquired Methicillin-Resistant Staphylococcus Aureus Infections In Chinese Neonates

HEALTH ALERT SWINE INFLUENZA SITUATION UPDATE UPDATED PATIENT TESTING PRIORITIZATION INTERIM GUIDANCE ON ANTIVIRALS

INFLUENZA-LIKE ILLNESS (ILI)

Influenza-Associated Hospitalization and Death Surveillance: Dallas County

Infectious Disease Diagnostics in the Geisinger Health System

Trends in Pneumonia and Influenza Morbidity and Mortality

Minnesota Influenza Geographic Spread

PULMONARY EMERGENCIES

Respiratory Syncytial Virus (RSV) in Older Adults: A Hidden Annual Epidemic. Webinar Agenda

Situation Update Pandemic (H1N1) August 2009

The Advisory Committee on Immunization

The Bacteriology of Bronchiectasis in Australian Indigenous children

2009 (Pandemic) H1N1 Influenza Virus

Hospital-acquired Pneumonia

Pharmacy and Referrals Pharmacy Name, Street Address & Telephone #: Primary Care Physician s Name, Location & Telephone #:

Influenza-Associated Pediatric Mortality rev Jan 2018

Frequently asked questions: Influenza (flu) information for parents. Seasonal influenza 2017/2018

Minnesota Influenza Geographic Spread

Minnesota Influenza Geographic Spread

Situation update pandemic (H1N1) 2009

Transcription:

STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Form approved OMB No. 0920-0007 Last Name: First Name: County: Address: City: State, Zip: Patient Demographics 1. State: 2. County: 3. State ID: 4. CDC ID: 5. Age: 9. Race: О Days О Months О Years 6. Date of birth: / / 7.Sex: О Male О Female О Unkown 8. Ethnicity: О Hispanic or Latino О Not Hispanic or Latino О Unknown White Black Asian Native Hawaiian or Other Pacific Islander American Indian or Alaska Native Death Information 10. Date of illness onset: / / 11. Date of death: / / 12. Was an autopsy performed? 13 a. Did cardiac/respiratory arrest occur outside the hospital? 13 b. Location of death: О Outside the Hospital (e.g. home or in transit to hospital) О Emergency Dept (ED) О Inpatient ward О ICU О Other (specify): 13 c. If the death occurred in the hospital, what was the date of admission? / / CDC Laboratory Specimens 14 a. Were pathology specimens sent to CDC s Infectious Diseases Pathology Branch? 14 b. Were influenza isolates or original clinical material sent to CDC s Influenza Division? 14 c. Were Staph aureus isolates sent to CDC s Division of Healthcare Quality Promotion? 1 of 5

Influenza Testing (check all that were used) Test Type Result Specimen Collection Date 15. Commercial rapid diagnostic test Viral culture Fluorescent antibody (IFA or DFA) Enzyme immunoassay (EIA) RT-PCR Immunohistochemistry (IHC) О Influenza A О Influenza B О Negative О Influenza A/B (Not Distinguished) О Influenza A О Influenza B О Negative Culture confirmation of bacterial pathogens from STERILE (Invasive) SITES 16 a. Was a specimen collected for bacterial culture from a normally sterile site (e.g., blood, cerebrospinal fluid [CSF], tissue, or pleural fluid 16 b. If yes, please indicate the site from which the specimen was obtained and the result. If more than one specimen type is positive and more than one organism is identified please indicate the organism cultured from each specimen type in the comments section. Specimen Type Collection Date Result Blood Date / / О Positive О Negative О Unknown Pleural fluid Date / / О Positive О Negative О Unknown CSF Date / / О Positive О Negative О Unknown Other Date / / О Positive О Negative О Unknown 16 c. If positive, please check the organism cultured. Streptococcus pneumoniae Group A streptococcus Other bacteria: (If reporting another viral co-infection please do so in section 19 Clinical Diagnosis and Complications) Staphylococcus aureus, methicillin sensitive (MSSA) Staphylococcus aureus, methicillin resistant (MRSA) Staphylococcus aureus, sensitivity not done Haemophilus influenzae not-type b Haemophilus influenzae type b Pseudomonas aeruginosa 2 of 5

Culture confirmation of bacterial pathogens from NON-STERILE SITES 16 d. Were other respiratory specimens collected for bacterial culture (e.g., sputum, ET tube aspirate)? 16 e. If yes, please indicate the site from which the specimen was obtained and the result. If more than one specimen type is positive and more than one organism is identified please indicate the organism cultured from each specimen type in the comments section. Specimen Type Collection Date Result Sputum Date / / О Positive О Negative О Unknown ET tube Date / / О Positive О Negative О Unknown Other Date / / О Positive О Negative О Unknown 16 f. If positive, please check the organism cultured. Streptococcus pneumoniae Group A streptococcus Other bacteria: (If reporting another viral coinfection please do so in section 19 Clinical Diagnosis and Complications) Staphylococcus aureus, methicillin sensitive (MSSA) Staphylococcus aureus, methicillin resistant (MRSA) Staphylococcus aureus, sensitivity not done Haemophilus influenzae not-type b Haemophilus influenzae type b Pseudomonas aeruginosa Pathology confirmation of bacterial pathogens 16 g. Was a specimen (e.g., fixed lung tissue) collected from an autopsy for testing of bacterial pathogens by a local or state pathologist? (If pathology results are available from CDC it is not necessary to input those results here, however please make sure to complete section 14 CDC Laboratory Specimens ) If yes please indicate the results of these tests in the comments section at the end of the form. Medical Care 17. Was the patient placed on mechanical ventilation? 3 of 5

Clinical Diagnoses and Complications 18 a. Did complications occur during the acute illness? 18 b. If yes, check all complications that occurred during the acute illness: Pneumonia (Chest X-Ray confirmed) Acute Respiratory Disease Syndrome (ARDS) Croup Seizures Bronchiolitis Encephalopathy/encephalitis Reye syndrome Shock Sepsis Hemorrhagic pneumonia/pneumonitis Cardiomyopathy/myocarditis Another viral co-infection: Other: 19 a. Did the child have any medical conditions that existed before the start of the acute illness? 19 b. If yes, check all medical conditions that existed before the start of the acute illness: Moderate to severe developmental delay Diabetes mellitus Hemoglobinopathy (e.g. sickle cell disease) History of febrile seizures Seizure disorder Asthma/ reactive airway disease Cystic fibrosis Cardiac disease/congenital heart disease (specify) Chromosomal Abnormality/Genetic Syndrome (specify) Chronic pulmonary disease (specify) Renal disease (specify) Skin or soft tissue infection (SSTI) Mitochondrial Disorder (specify) Immunosuppressive condition (specify) Cancer (diagnosis and/or treatment began in previous 12 months) (specify) Endocrine disorder (specify) Obesity Cerebral Palsy Prematurity (specify gestational age) weeks Neuromuscular disorder (e.g. muscular dystrophy) (specify) Pregnant (specify gestational age) weeks Other Neurological disorder (specify) Other (specify) Medication and Therapy History 20 a. Was the patient receiving any of the following therapies prior to illness onset? (if yes, check all that apply) Yes No Antiviral Prophylaxis Chronic aspirin therapy Chemotherapy or radiation therapy Steroids by mouth or injection other immunosuppressive therapy: 20 b. Did the patient receive any of the following after illness onset? (if yes, check all that apply) Yes No Antibiotic therapy specify Antiviral therapy specify 4 of 5

Influenza Vaccine History 21. Did the patient receive any seasonal influenza vaccine during the current season (before illness) 22. If YES*, please specify the seasonal influenza vaccine received before illness onset: Trivalent inactivated influenza vaccine (TIV) [injected] Live-attenuated influenza vaccine (LAIV) [nasal spray] 23. If YES for seasonal vaccine*, how many doses did the patient receive and what was the timing of each dose? (Enter vaccination dates if available) О 1 dose ONLY О 2 doses <14 days prior to illness onset >14 days prior to illness onset 2 nd dose given <14 days prior to onset 2 nd dose given >14 days prior to onset Date dose given: / / Date of 1 st dose: / / Date of 2 nd dose: / / 24. Did the patient receive any seasonal influenza vaccine in previous seasons? 24 a. If YES to question 24, and patient was between 6 months and 8 years of age at the time of death, was the 2009-2010 influenza season the first time the patient received seasonal influenza vaccine? 24b. If YES to question 24a, did the patient receive 2 doses of seasonal influenza vaccine during the 2009-2010 influenza season? 25. If the patient was between 6 months and 8 years of age at the time of death, did they receive at least one dose of 2009 influenza A (H1N1) vaccine during the previous season? Submitted By: Date: / / Phone No.: ( ) - E-mail Address: Public reporting burden of this collection of information is estimated to average 20 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS E-11, Atlanta, Georgia 30333; ATTN: PRA (0920-0007). 5 of 5